date,title,source
Oct-24-18,GlycoMimetics to Present at Upcoming Investor Conferences,Business Wire
Oct-26-18,"GlycoMimetics to Report Third Quarter 2018 Financial Results on November 2, 2018",Business Wire
Nov-01-18,GlycoMimetics to Present Analyses from Phase 1/2 AML Trial of Uproleselan at 60th ASH Meeting,Business Wire
Nov-06-18,"Report: Developing Opportunities within Stryker, Anavex Life Sciences, Engility, Baker Hughes, a GE company, GlycoMimetics, and HCP  Future Expectations, Projections Moving into 2018",GlobeNewswire
Nov-15-18,Edited Transcript of GLYC earnings conference call or presentation 2-Nov-18 12:30pm GMT,Thomson Reuters StreetEvents
Nov-16-18,Edited Transcript of GLYC earnings conference call or presentation 2-Nov-18 12:30pm GMT,Thomson Reuters StreetEvents
Nov-19-18,GlycoMimetics Enrolls First Patient in Global Phase 3 Clinical Trial of Uproleselan in Relapsed/Refractory Acute Myeloid Leukemia,Business Wire
Nov-27-18,3 Top Biotech Stocks to Buy Right Now,Motley Fool
Nov-28-18,"Scott Jackson, Veteran Biopharmaceutical Executive, Joins GlycoMimetics Board of Directors",Business Wire
Nov-29-18,"GlycoMimetics to Host 2018 Investor/Analyst Meeting at 60th ASH Annual Meeting on December 3, 2018",Business Wire
Dec-03-18,GlycoMimetics Presents New AML Data with Uproleselan at 60th ASH Annual Meeting,Business Wire
Dec-04-18,GlycoMimetics Posters at 60th ASH Annual Meeting Highlight Preclinical Data on Two New Proprietary Drug Candidates,Business Wire
Dec-12-18,"Heres What We Think About GlycoMimetics, Inc.s (NASDAQ:GLYC) CEO Pay",Simply Wall St.
Feb-11-19,"Detailed Research: Economic Perspectives on Waddell & Reed Financial, Kennametal, Automatic Data Processing, Trustmark, Eagle Bulk Shipping, and GlycoMimetics  What Drives Growth in Today's Competitive Landscape",GlobeNewswire
Feb-27-19,"GlycoMimetics to Report Fourth Quarter and Year-End 2018 Financial Results on March 6, 2019",Business Wire
